Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion

Clinical Transplantation

Volumn 14, Issue 6, 2000, Pages 561-566

  Thervet, Eric ^a   Morelon, Emmanuel ^b   Ducloux, Didier ^c   Bererhi, Linda ^a   Noël, Laure Hélène ^b   Janin, Anne ^a   Bedrossian, Janine ^a   Puget, Sophie ^d   Chalopin, Jean Marc ^c   Mihatsch, Michael ^e   Legendre, Christophe ^a   Kreis, Henri ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL SAINT JACQUES   (France)

^d Produits Roche   (France)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Acute rejection; Azathioprine mycophenolate mofetil; Cyclosporine withdrawal; Histologic deterioration; Nephrotoxicity

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3;

ACUTE DISEASE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; GRAFT REJECTION; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; INULIN CLEARANCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PATIENT SELECTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; BIOPSY; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INULIN; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID;

EID: 0033659696     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.140608.x     Document Type: Article

References (26)

1. Causes of renal allograft loss: Progress in the 1980s, challenges for the 1990s
2. Causes of kidney allograft loss in a large pediatric population at a single center
3. Elective cyclosporine after renal transplantation: A meta-analysis
4. A controlled trial of cyclosporine withdrawal in renal transplantation with conversion to azathioprine and prednisolone after three months
5. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
6. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
7. A novel approach to the treatment of chronic allograft nephropathy
8. Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity. A preliminary report
9. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: First-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients
10. Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function
11. The Banff 97 working classification of renal allograft pathology
12. A randomized clinical trial of cyclosporine in cadaveric renal transplantation: Analysis at three years
13. Survival trends in long-term first cadaver-donor kidney transplants
14. Chronic rejection
15. The incidence and impact of early rejection episodes of graft outcome in recipients of first cadaver kidney transplants
16. The impact of an acute rejection episode on long-term renal allograft survival (t( 1/2 ))
17. Hypercholestrolemia in long-term survivors of heart transplantation: An early marker of accelerated coronary heart disease
18. Preliminary results of a randomised, controlled study investigating the withdrawal of Neoral in stable renal transplant recipients receiving mycophenolate mofetil in addition to Neoral and steroids
19. Withdrawal of cyclosporine or prednisone in, renal transplant recipients treated with mycophenolate mofetil, cyclosporine and prednisone: A randomised study
20. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclsporine. A report of the FK506 kidney transplant study group
21. Designing studies to measure the benefit of low-toxicity regimens
22. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema
23. Beneficial effects of treatment of early subclinical rejection: A randomized study
24. Histopathological findings in well-functioning, long-term renal allografts
25. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients
26. Hyperlipidaemia in renal transplantation - Risk factor for long-term graft outcome